{
  "ptid_time": "057_S_5292_2015-10-28",
  "img_path": "/data/qiuhui/data/adni/images/057_S_5292/2015-10-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,160 mm³, 38.9% below the reference mean. With a Z-score of -0.89 (18.7th percentile), this represents normal volume ; hippocampal volume measures 6,918 mm³, 2.8% below the reference mean. With a Z-score of -0.25 (40.0th percentile), this represents normal volume ; whole brain volume measures 980,610 mm³, 0.6% above the reference mean. With a Z-score of 0.08 (53.1th percentile), this represents normal volume ; entorhinal cortex volume measures 3,791 mm³, 3.2% above the reference mean. With a Z-score of 0.20 (57.8th percentile), this represents normal volume ; fusiform gyrus volume measures 17,376 mm³, 2.1% above the reference mean. With a Z-score of 0.19 (57.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,196 mm³, 10.3% below the reference mean. With a Z-score of -0.89 (18.6th percentile), this represents normal volume . ",
  "text_data": "Age is 76.3 years. Gender is Female. Education: 13 years. MMSE: 29.0. MoCA: 28.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.49 SUVR (profound elevated); Amyloid beta: 915.40 pg/mL (normal ); Total tau: 394.90 pg/mL (moderate elevated); Phosphorylated tau: 40.95 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volumes (hippocampus, entorhinal cortex, fusiform gyrus, etc.) are within normal ranges, and cognitive scores (MMSE 29, MoCA 28) are intact. However, elevated P-tau and AV45 (amyloid PET) suggest Alzheimer’s pathology, while T-tau is moderately elevated, possibly indicating neurodegeneration. Despite normal cognition, biomarker evidence points to early pathology.  \n\n**Diagnosis:** **MCI (Mild Cognitive Impairment, likely due to Alzheimer’s pathology)**  \n**Confidence:** **Medium** (Cognitive scores are strong, but biomarkers strongly suggest early disease progression.)  \n\n*Note: Given the normal cognition, this could also be considered \"preclinical Alzheimer’s,\" but MCI is more clinically actionable. If cognitive decline progresses, dementia diagnosis would follow.*",
  "timestamp": "2025-07-26T08:15:19.019215"
}